Scott Yerganian

Scott Yerganian joined Flagship Pioneering in 2025 as Vice President, Growth. In this role, he supports the development and scaling of companies across the ecosystem, collaborating with Flagship and GrowthCo executive teams on long-term value creation strategy.

Before joining Flagship, Scott held multiple roles across academia, diagnostics, and therapeutics. Most recently, he was Vice President of Business Development and Alliance Management at Ikena Oncology. He joined Ikena as an early employee and supported the Series B and IPO financings, developed the corporate strategy, and led various licensing and M&A transactions. Prior to his six years at Ikena, he spent five years at Foundation Medicine, where he helped build the biopharma business. Scott began his career at Memorial Sloan-Kettering Cancer Center operationalizing Phase 1 clinical trials.

Scott received his B.A.S. from the University of Pennsylvania, where he studied Bioengineering and Engineering Entrepreneurship.